Last reviewed · How we verify

NCT03798704

Comparison of IFA and LIAISON® for Diagnosis of Early Disseminated Lyme Borreliosis in Children, Younger Than 18 Years

Completed Last updated 30 April 2021
What this trial tests

trial testing IFA, LIAISON in Lyme Disease in 349 participants. Completed in 31 December 2020.

Timeline
29 January 2019
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorUniversity Medical Centre Ljubljana
StatusCompleted
Study typeOBSERVATIONAL
Enrollment349
Start date29 January 2019
Primary completion31 December 2020
Estimated completion31 December 2020
Sites1 location across Slovenia

Drugs / interventions tested

Conditions studied

Sponsor

University Medical Centre Ljubljana

Who can join

Under 18, any sex, with Lyme Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare two different serological tests, IFA and LIAISON, for detection of Borrelia burgdorferi sensu lato IgM and IgG antibiodies in children with early disseminated Lyme borreliosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lyme Disease

Currently open trials in the same condition.

Other University Medical Centre Ljubljana trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03798704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing